OTC · Financial Statements
Hemostemix Inc (HMTXF) Financial Statements
$0.05
OTC: HMTXF
Market Cap $9.22M
Overview Financials Dividend Hemostemix Inc most recently reported annual revenue of $0, net profit of $-5.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-7.0M $-3.0M $-2.0M $-2.0M $-6.0M Net Profit $-6.0M $-5.0M $-3.0M $-3.0M $-5.0M EPS $-0.11 $-0.07 $-0.03 $-0.03 $-0.03 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $1.0M $0 $0 $1.0M $1.0M Total Liabilities $6.0M $7.0M $8.0M $8.0M $6.0M Cash $0 $0 $0 $1.0M $1.0M Borrowings $1.0M $4.0M $4.0M $5.0M $4.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-3.0M $-6.0M $-1.0M $-2.0M $-5.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $0 $0 $0 $1.0M $0 Free Cash Flow $-3.0M $-6.0M $-1.0M $-2.0M $-5.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.02 EV / EBITDA -4.00 FCF Yield -47.92% Quick Ratio 0.24 Interest Coverage -10.59 Return 1Y -40.04% Return 3Y -38.05% Return 5Y —
Screens featuring this stock